Apogee Therapeutics Inc.
40.99
1.65 (4.19%)
At close: Jan 15, 2025, 10:48 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22
Revenue n/a n/a
Cost of Revenue n/a n/a
Gross Profit n/a n/a
Operating Income -93.00M -30.73M
Interest Income 9.02M 92.00K
Pretax Income -83.98M -39.78M
Net Income -83.98M -39.78M
Selling & General & Admin 24.58M 2.94M
Research & Development 68.42M 27.79M
Other Expenses n/a n/a
Operating Expenses 93.00M 30.73M
Interest Expense n/a 9.15M
Selling & Marketing Expenses n/a n/a
Cost & Expenses 93.00M 30.73M
Income Tax n/a -33.52K
Shares Outstanding (Basic) 50.66M 50.67M
Shares Outstanding (Diluted) 50.66M 50.67M
EPS (Basic) -1.66 -0.79
EPS (Diluted) -1.66 -0.79
EBITDA -83.98M n/a
Depreciation & Amortization 9.02M 33.52M